Abstract

The Global Program to Eliminate Lymphatic Filariasis (GPELF) advocates for the treatment of entire endemic communities, in order to achieve its elimination targets. LF is predominantly a rural disease, and achieving the required treatment coverage in these areas is much easier compared to urban areas that are more complex. In Ghana, parts of the Greater Accra Region with Accra as the capital city are also endemic for LF. Mass Drug Administration (MDA) in Accra started in 2006. However, after four years of treatment, the coverage has always been far below the 65% epidemiologic coverage for interrupting transmission. As such, there was a need to identify the reasons for poor treatment coverage and design specific strategies to improve the delivery of MDA. This study therefore set out to identify the opportunities and barriers for implementing MDA in urban settings, and to develop appropriate strategies for MDA in these settings. An experimental, exploratory study was undertaken in three districts in the Greater Accra region. The study identified various types of non-rural settings, the social structures, stakeholders and resources that could be employed for MDA. Qualitative assessment such as in-depth interviews (IDIs) and focus group discussions (FGDs) with community leaders, community members, health providers, NGOs and other stakeholders in the community was undertaken. The study was carried out in three phases: pre-intervention, intervention and post-intervention phases, to assess the profile of the urban areas and identify reasons for poor treatment coverage using both qualitative and quantitative research methods. The outcomes from the study revealed that, knowledge, attitudes and practices of community members to MDA improved slightly from the pre-intervention phase to the post-intervention phase, in the districts where the interventions were readily implemented by health workers. Many factors such as adequate leadership, funding, planning and community involvement, were identified as being important in improving implementation and coverage of MDA in the study districts. Implementing MDA in urban areas therefore needs to be given significant consideration and planning, if the required coverage rates are to be achieved. This paper, presents the recommendations and strategies for undertaking MDA in urban areas.

Highlights

  • Lymphatic Filariasis (LF) is a significant health problem in many developing countries with over 1 billion people believed to be at risk in endemic areas [1,2]

  • In the Greater Accra region there was need to identify the reasons for poor treatment coverage in order to design specific strategies to improve the delivery of Mass Drug Administration (MDA)

  • In the process of this study, it became much clearer to the NTD programme that leadership, funding, planning and community involvement are very important in the success of MDA campaigns in urban areas

Read more

Summary

Introduction

Lymphatic Filariasis (LF) is a significant health problem in many developing countries with over 1 billion people believed to be at risk in endemic areas [1,2]. The World Health Assembly passed a resolution in 1997 to eliminate LF by the year 2020. In the year 2000, the World Health Organization launched the global programme to eliminate LF [5]. The strategy employed involves annual mass treatment with single-dose diethylcarbamazine (DEC) or Ivermectin (IVM) in combination with Albendazole (ALB) for 4–6 years. This is the principal strategy of LF elimination. The strategy is backed by studies that have shown that one or two annual treatments with antifilarial drugs exert only limited effects on microfilaria rates and intensities and multiple rounds of treatment are necessary to reduce the microfilaria prevalence to zero [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call